Navigation Links
New materials, progress toward an HIV vaccine, and more at meeting of crystallographers

WASHINGTON D.C., July 1, 2013 New materials and potential new drug targets are just some of the discoveries featured this month at a major scientific meeting on the structure of molecules. More information on the conference program and press releases will be disseminated in mid-July.

The Annual Meeting of the American Crystallographic Association (ACA) will be held July 20 24, 2013, at the Sheraton Waikiki Beach Hotel in Honolulu, Hawaii. Crystallography is the science devoted to exploring the arrangement of atoms in regular crystalline solids and in complicated molecules. Scientists will present research spanning medicine, genomics, material science, structural biology, and other diverse disciplines.

Preliminary meeting highlights appear below. For more information, reporters can contact Catherine Meyers (, 301-209-3088).

Visualizing the HIV vs. Immune System Arms Race

"Highly effective neutralizing antibodies have been isolated from about two dozen HIV-1 infected individuals.... We followed the development of a CD4-binding site antibody, CH103, in a donor from time of infection...."

Abstract 01.02.20:

Materials that Expand Under Pressure

"Negative linear compressibility (NCL) is a rare but desirable property whereby a material's crystal structure actually expands in one direction against increasing hydrostatic pressure.... In zinc(II) dicyanoaurate (I) so-called "giant" NLC is observed for the first time with the crystal structure expanding more than 10 percent over 1.8 GPa...."

Abstract 13.06.8:

Bacteria in the Gut Targeted to Eliminate Some Negative Drug Reactions

"Our goal is to improve both patient tolerance and overall drug efficacy by using structural and chemical biology to potently target an intestinal microbial enzyme."

Abstract 13.01.3:

Facebook for Minerals

"CEO Mark Zuckerberg, in Jan 2013 announced to employ graph-search where the entire Facebook is expressed as a graph of infinitely extensible collection of documents.... We have been developing rule-based approaches to create such indexes for a warehouse of chemical structures and biomedical data."

Abstract 03.01.11:

Photosynthetic Proteins Caught in Action

"We believe that we have visualized the protein-quake that occurs as a large amount of energy is absorbed by a light-driven protein and this energy is rapidly dissipated into the surrounding solvent before the protein unfolds."

Abstract 11.03.10:

Anti-Plague Drugs

"Yersinia pestis, the causative agent of bubonic plague and a potential bioweapons agent, requires a highly active protein tyrosine phosphatase, YopH, for pathogenicity. We have identified a potent and non-promiscuous inhibitor with good selectivity against a panel of phosphatases that exhibits significant inhibition of intracellular Y. pestis replication."

Abstract 12.02.13:

New Ways to Fight Superbugs

"Gram negative bacteria (GNB) are becoming increasingly resistant to our current arsenal of antibiotics with new strains of multi-drug resistant (MDR) bacteria arising with greater frequency. A genomic screen for new antibiotics targets in the MDR GNB Acinetobacter baumannii was performed and yielded several unrecognized or underexploited targets."

Abstract 13.01.37:

Pressure Makes New Materials

"Two different approaches, in particular, have been successful in the creation of new compounds: direct synthesis under elevated pressure and temperature, and chemical transformation of a compound through the use of pressure."

Abstract 13.15.3:

Green Chemistry

"Our research group is using solid-state reactions to develop general methodologies for solvent-free and low-energy synthesis."

Abstract 13.15.6:


Contact: Catherine Meyers
American Institute of Physics

Related biology news :

1. Optical boomerangs, ultralight fractal materials, and more
2. Recent progress in gene-sensing strategies for rapid detection of foodborne pathogens
3. Progress in introducing cleaner cook stoves for billions of people worldwide
4. University of Montreal researchers discover how drug prevents aging and cancer progression
5. Genetic alterations linked with bladder cancer risk, recurrence, progression, and patient survival
6. Hastings Center resources chart progress in debate over medical research with animals
7. First special edition updating progress on efforts to map human proteins
8. Transplanted neural stem cells slows als onset and progression in mouse models
9. Predictors of cancer disease progression improve patient selection for metastasis-directed therapy
10. Researchers use blood testing to predict level of enzymes that facilitate disease progression
11. BUSM researchers find potential key to halt progression, reverse damage from emphysema
Post Your Comments:
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... 2015  The J. Craig Venter Institute (JCVI) policy ... and Biosecurity: Lessons Learned and Options for the Future," ... Human Services guidance for synthetic biology providers has worked ... --> --> Synthetic biology promises ... to pose unique biosecurity threats. It now is easier ...
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica ... on AngelList early in their initial angel funding process. Now, they are paying ... looking to make early stage investments in the microbiome space. In this, ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
(Date:11/24/2015)... India , November 24, 2015 ... a new market research report "Oligonucleotide Synthesis Market by ... Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, ... 2020", published by MarketsandMarkets, the market is expected to ... Million in 2015, at a CAGR of 10.1% during ...
Breaking Biology Technology: